Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...

Our high sports photos, like the ones above, put you in the middle of the action. Check them out by clicking anywhere in the collage to open the photo gallery. Don’t forget to share the gallery ...

LOS ANGELES — It's 10 a.m. on a Friday at SURFCORE Fitness, a boutique gym in Mid-City, and a 52-year-old woman is following an exercise circuit as her trainer watches on. The fashion consultant ...

“Let’s address the elephant in the comments section. I am not on Ozempic. I am not sick. I didn’t get a face transplant and I didn’t get a brow lift,” Burke, 41, said in a video shared ...

Some ways you can manage ADHD stigma in the workplace include playing to your strengths, communicating positively, and leaning into how your brain operates. According to the American Psychological ...

Moody’s lowered the rating from a gold-standard Aaa to Aa1 but said the United States “retains exceptional credit strengths such as the size, resilience and dynamism of its economy and the role of the ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

Lars Fruergaard Jørgensen, president and CEO of Novo Nordisk, testifies during a Senate Health, Education, Labor and Pensions hearing to examine Novo Nordisk’s high prices for Ozempic and Wegovy for ...

Shares had skyrocketed after the introduction of Wegovy and diabetes medicine Ozempic, which are both based on the same basic ingredient, semaglutide. At the peak, the company’s market ...

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted ... Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo's ...

Ozempic maker Novo Nordisk NOVO.B-0.94%decrease; red down pointing triangle pushed out its chief executive after losing ground in the anti-obesity drug market, which has caused a steep stock-price ...